Oxtriphylline

  • TRADE NAMES: Choledyl (Pfizer); Choledyl SA (Warner Chilcott); Oxtriphylline Pediatric; Theobret
  • INDICATIONS: Asthma, chronic bronchitis, emphysema, bronchospastic disorders
  • CLASS: Bronchodilator
  • HALF-LIFE: 1–9 hours in pediatric patients; 3–15 hours in non-smoking adults; 4–5 hours in cigarette smokers

Our database has 2 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

OTHER.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top